These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2063707)

  • 1. The role of lipid abnormalities in the pathogenesis of chronic, progressive renal disease.
    Kasiske BL; O'Donnell MP; Schmitz PG; Keane WF
    Adv Nephrol Necker Hosp; 1991; 20():109-25. PubMed ID: 2063707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids in progression of renal disease.
    Oda H; Keane WF
    Kidney Int Suppl; 1997 Nov; 62():S36-8. PubMed ID: 9350676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia and progressive renal disease.
    Keane WF; Mulcahy WS; Kasiske BL; Kim Y; O'Donnell MP
    Kidney Int Suppl; 1991 Apr; 31():S41-8. PubMed ID: 2046270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesis.
    Shohat J; Boner G
    Isr J Med Sci; 1993 Apr; 29(4):228-39. PubMed ID: 8491578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids and the progression of renal disease.
    Keane WF; O'Donnell MP; Kasiske BL; Schmitz PG
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF; St Peter JV; Kasiske BL
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids and renal disease.
    Trevisan R; Dodesini AR; Lepore G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S145-7. PubMed ID: 16565240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN
    Miner Electrolyte Metab; 1993; 19(3):127-36. PubMed ID: 8232099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is hyperlipidemia a factor in the progression of renal failure?].
    Geiger H
    Z Kardiol; 1993; 82 Suppl 4():35-8. PubMed ID: 8147060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary manipulation on the lipid abnormalities in patients with chronic renal failure.
    Maschio G; Oldrizzi L; Rugiu C; De Biase V; Loschiavo C
    Kidney Int Suppl; 1991 Apr; 31():S70-2. PubMed ID: 2046274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids and progressive kidney disease.
    Moorhead JF
    Kidney Int Suppl; 1991 Apr; 31():S35-40. PubMed ID: 2046269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.
    Stevenson FT; Kaysen GA
    Wien Klin Wochenschr; 1999 Apr; 111(8):307-14. PubMed ID: 10378311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of chronic renal disease.
    Klahr S
    Nutrition; 1990; 6(3):207-12. PubMed ID: 2135999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical strategies for arresting progression of renal disease.
    ter Wee PM; Donker AJ
    Kidney Int Suppl; 1992 Oct; 38():S114-20. PubMed ID: 1405361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic implications of lipid-lowering agents in the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP; Schmitz PG
    Am J Med; 1989 Nov; 87(5N):21N-24N. PubMed ID: 2486540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of serum and membrane lipid composition induced by diet in patients with chronic renal failure.
    Loschiavo C; Ferrari S; Aprili F; Grigolini L; Faccini G; Maschio G
    Clin Nephrol; 1990 Dec; 34(6):267-71. PubMed ID: 2073770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.